- Home
- SHPH vs ATNF Comparison
SHPH vs ATNF Comparison
Compare SHPH & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHPH
- ATNF
- Stock Information
- Founded
- SHPH 2012
- ATNF 2016
- Country
- SHPH United States
- ATNF United States
- Employees
- SHPH N/A
- ATNF N/A
- Industry
- SHPH Biotechnology: Pharmaceutical Preparations
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- SHPH Health Care
- ATNF Health Care
- Exchange
- SHPH Nasdaq
- ATNF Nasdaq
- Market Cap
- SHPH 2.7M
- ATNF 2.6M
- IPO Year
- SHPH 2022
- ATNF N/A
- Fundamental
- Price
- SHPH $0.64
- ATNF $1.74
- Analyst Decision
- SHPH
- ATNF
- Analyst Count
- SHPH 0
- ATNF 0
- Target Price
- SHPH N/A
- ATNF N/A
- AVG Volume (30 Days)
- SHPH 74.0K
- ATNF 128.8K
- Earning Date
- SHPH 11-13-2024
- ATNF 02-13-2025
- Dividend Yield
- SHPH N/A
- ATNF N/A
- EPS Growth
- SHPH N/A
- ATNF N/A
- EPS
- SHPH N/A
- ATNF N/A
- Revenue
- SHPH N/A
- ATNF N/A
- Revenue This Year
- SHPH N/A
- ATNF N/A
- Revenue Next Year
- SHPH N/A
- ATNF $54.15
- P/E Ratio
- SHPH N/A
- ATNF N/A
- Revenue Growth
- SHPH N/A
- ATNF N/A
- 52 Week Low
- SHPH $0.61
- ATNF $1.16
- 52 Week High
- SHPH $4.94
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- SHPH 27.09
- ATNF 32.45
- Support Level
- SHPH $0.61
- ATNF $1.69
- Resistance Level
- SHPH $0.79
- ATNF $2.26
- Average True Range (ATR)
- SHPH 0.06
- ATNF 0.19
- MACD
- SHPH 0.00
- ATNF -0.02
- Stochastic Oscillator
- SHPH 12.15
- ATNF 4.61
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.